News for 'Data Scientists'

'Covid vaccine will be equally effective against new mutant'

'Covid vaccine will be equally effective against new mutant'

Rediff.com21 Dec 2020

The CSIR DG said the transmissibility of the new strain N501Y is a "bit higher" but this does not mean it is more lethal and more people are going to die due to it.

PM Modi gives tight hug to emotional ISRO chief

PM Modi gives tight hug to emotional ISRO chief

Rediff.com7 Sep 2019

Modi, in his address at the ISRO centre asked the scientists not to get disheartened by the hurdles in the lunar mission Chandrayaan-2 and asserted that there will be a "new dawn".

Covid vaccine boosters not appropriate at this stage: Lancet study

Covid vaccine boosters not appropriate at this stage: Lancet study

Rediff.com13 Sep 2021

The results reported from the observational studies, on average, show that vaccination had 95 per cent efficacy against severe disease both from the Delta variant and from the Alpha variant, and over 80 per cent efficacy at protecting against any infection from these variants.

Study says coronavirus infects heart cells of patients

Study says coronavirus infects heart cells of patients

Rediff.com1 Jul 2020

"We not only uncovered that these stem cell-derived heart cells are susceptible to infection by novel coronavirus, but that the virus can also quickly divide within the heart muscle cells," said study co-author Arun Sharma from the Cedars-Sinai Board of Governors Regenerative Medicine Institute in the United States. "Even more significant, the infected heart cells showed changes in their ability to beat after 72 hours of infection," Sharma said.

'Omicron is a very, very obvious case for boosters'

'Omicron is a very, very obvious case for boosters'

Rediff.com27 Dec 2021

'An individual who maybe has had two vaccines, or has had two vaccines, and a booster, is going to be pretty well protected.'

Congress raises 'Chinese surveillance' issue in RS

Congress raises 'Chinese surveillance' issue in RS

Rediff.com16 Sep 2020

The Chinese company has also collected the data base of bureaucrats in key positions, judges, scientists, academicians, journalists, actors, sportspersons, religious figures and activists, he added.

India administers over 100 crore anti-Covid jabs

India administers over 100 crore anti-Covid jabs

Rediff.com21 Oct 2021

The prime minister also visited the Ram Manohar Lohia Hospital in New Delhi after the milestone was achieved and interacted with hospital officials.

New Omicron sub-variant detected in countries like India: WHO

New Omicron sub-variant detected in countries like India: WHO

Rediff.com7 Jul 2022

A new sub-lineage BA.2.75 of the Omicron variant of the coronavirus has been detected in countries like India and the World Health Organisation is following this, Director-General Tedros Adhanom Ghebreyesus said.

Expert panel recommends granting emergency nod to Oxford vaccine

Expert panel recommends granting emergency nod to Oxford vaccine

Rediff.com2 Jan 2021

As for Bharat Biotech, the Subject Expert Committee (SEC) on COVID-19 of the CDSCO asked the firm to expedite volunteer recruitment for the ongoing clinical trial and said it may conduct interim efficacy analysis for further consideration of restricted emergency use approval for its vaccine Covaxin, they stated.

Can depression be traced back to your genes?

Can depression be traced back to your genes?

Rediff.com19 Apr 2018

A new research has pinpointed some genes that can trigger depression.

With Omicron, 3rd wave projected to hit India by Feb

With Omicron, 3rd wave projected to hit India by Feb

Rediff.com6 Dec 2021

With Omicron, the new variant of SARS-CoV2, the third wave of coronavirus could hit the peak by February with cases likely to be reaching up to 1-1.5 lakh a day in the country, but it will be milder than the second wave, Manindra Agarwal, IIT scientist involved in the mathematical projection of trajectory of COVID-19, said.

COVID-19: Prominent Indian-origin virologist dies in South Africa

COVID-19: Prominent Indian-origin virologist dies in South Africa

Rediff.com1 Apr 2020

Gita Ramjee has become the first Indian-origin South African to have died after contracting the novel coronavirus. Ramjee, a stellar vaccine scientist and an HIV prevention research leader, had returned from London a week ago but reportedly showed no symptoms of COVID-19.

It will take India 600 days to vaccinate 1 billion people

It will take India 600 days to vaccinate 1 billion people

Rediff.com15 Apr 2021

The data gaps are inhibiting sound decisions. We need to know seroprevalence, infection, and vaccination rates. This is required in 200 cities of India, every week, suggests Ajay Shah.

Breakthrough Covid infections in India within expected numbers: INSACOG

Breakthrough Covid infections in India within expected numbers: INSACOG

Rediff.com1 Sep 2021

When a person gets an infection even after being vaccinated against it, it is called a breakthrough case.

Covaxin shows 78% efficacy in phase-3 interim analysis

Covaxin shows 78% efficacy in phase-3 interim analysis

Rediff.com21 Apr 2021

Safety and Efficacy results from the final analysis will be available in June, and the final report will be submitted to a peer-reviewed publication.

Coronavirus hits children less severely than adults, says study

Coronavirus hits children less severely than adults, says study

Rediff.com14 Mar 2020

'However, the importance of children in transmitting the virus remains uncertain,' the scientists cautioned in the study. 'Coronaviruses are a large family of viruses that can cause infection and disease in animals, capable of rapid mutation and recombination, leading to novel viruses that can spread from animals to humans,' they said.

Covishield, Covaxin effective against 'Indian strain' of Covid, study suggests

Covishield, Covaxin effective against 'Indian strain' of Covid, study suggests

Rediff.com27 Apr 2021

Anurag Agrawal, the Director of the Institute of Genomics and Integrative Biology, said the study on effectiveness of the available vaccines on the B.1.617 variant of SARS-CoV2 suggests that post vaccination, the infections are milder.

Phase II trial finds Chinese COVID-19 vaccine is safe

Phase II trial finds Chinese COVID-19 vaccine is safe

Rediff.com21 Jul 2020

Since the trial participants were not exposed to the coronavirus after vaccination, the scientists said it is not possible for the current study to determine the efficacy of the candidate vaccine.

Cherrapunji: Rainfall in past 24 hrs is 3rd highest in 122 yrs

Cherrapunji: Rainfall in past 24 hrs is 3rd highest in 122 yrs

Rediff.com17 Jun 2022

Just two days after recording 811.6 mm of rainfall in a day, Cherrapunji in Meghalaya received a bountiful 972 mm of precipitation in 24 hours ending 8.30 am on Friday, the highest in June since 1995 and the third highest in 122 years, the India Meteorological Department (IMD) said.

Indian advertising agencies are changing

Indian advertising agencies are changing

Rediff.com11 Feb 2019

'The list of things to be done or added or removed will keep growing and it will be a while before the emerging models settle down into lasting structures,' predicts Umesh Shrikhande, CEO, Taproot Dentsu.

Covid: Big 3rd wave unlikely in India, say experts

Covid: Big 3rd wave unlikely in India, say experts

Rediff.com23 Nov 2021

Is the worst of the Covid crisis behind India? As cases dip three weeks after Diwali, the answer is a possible yes, say several experts, attributing the downslide to a large section of the population already exposed to the virus during the second wave and a stepped up vaccination campaign.

Nod for Covid vaccine in next few days: Serum Institute's Poonawalla

Nod for Covid vaccine in next few days: Serum Institute's Poonawalla

Rediff.com29 Dec 2020

The Serum Institute of India has stockpiled 40 mn-50 mn doses and is adding more every week. Most of these will come to India.

India readies 5 sites for final phase of trials of Oxford COVID vaccine

India readies 5 sites for final phase of trials of Oxford COVID vaccine

Rediff.com28 Jul 2020

The Serum Institute of India, the largest vaccine maker in the world, has been chosen by Oxford and its partner AstraZeneca to manufacture the vaccine once it is ready. Trials results for the first two phases were published earlier this month.

NASA/ESA spacecraft to give first images of Sun's poles

NASA/ESA spacecraft to give first images of Sun's poles

Rediff.com10 Feb 2020

Solar Orbiter is on a unique trajectory that will allow its comprehensive set of instruments to provide humanity with the first-ever images of the Sun's poles, the US space agency said. This trajectory includes 22 close approaches to the Sun, bringing the spacecraft within the orbit of Mercury to study the Sun, and its influence on space, it said.

IMA requests its 3.5 lakh members to voluntarily get vaccinated

IMA requests its 3.5 lakh members to voluntarily get vaccinated

Rediff.com11 Jan 2021

"The Indian Medical Association has requested all its 3.5 lakh members in 1,800 local branches to voluntarily come out to get vaccinated first to show the world that these vaccines are safe and efficacious," it said.

Start-up India: Bloodbath on job street

Start-up India: Bloodbath on job street

Rediff.com10 May 2017

Online marketplace majors, e-grocers, Internet of Things firms, app-based companies and transport service aggregators are among those that have had to shut shop or scale down operations. Now, survival skills like upskilling and retraining will determine who makes it.

India's excess Covid deaths may be between 3.4- 4.9mn: Study

India's excess Covid deaths may be between 3.4- 4.9mn: Study

Rediff.com21 Jul 2021

India's official COVID-19 tally on Wednesday was 4,18,480 (4.18 lakh), the third highest in the world after the US and Brazil.

PM directs full preparedness for vaccine distribution

PM directs full preparedness for vaccine distribution

Rediff.com17 Oct 2020

In a statement, the PMO said three vaccines are in advanced stages of development in India, out of which two are in Phase II and one is in Phase-III. It further said Indian Scientists and research teams are collaborating and strengthening the research capacities in neighbouring countries such as Afghanistan, Bhutan, Bangladesh, Maldives, Mauritius, Nepal and Sri Lanka.

Omicron: 'Vaccine immunity may be less effective'

Omicron: 'Vaccine immunity may be less effective'

Rediff.com7 Dec 2021

'Antiviral treatment will have no change. Spike protein change may affect the immunity protection.'

Covid vaccine: Too early to say if booster dose needed

Covid vaccine: Too early to say if booster dose needed

Rediff.com30 Apr 2021

Initial data has shown immunity triggered by the two mRNA vaccines -- Pfizer-BioNTech and Moderna -- lasts for at least six months

Men more likely to suffer severe effects of COVID-19 than women: Study

Men more likely to suffer severe effects of COVID-19 than women: Study

Rediff.com29 Apr 2020

Based on the observations, scientists said that additional care may be required for older men or those with underlying conditions. Yang and his team analysed several patient datasets to see if there were differences in how men and women respond to COVID-19.

Districts in MP, Bihar, Telangana most vulnerable to Covid: Study

Districts in MP, Bihar, Telangana most vulnerable to Covid: Study

Rediff.com17 Jul 2020

The study noted that nine of 30 large states -- Madhya Pradesh, Bihar and Telangana, Jharkhand, Uttar Pradesh, Maharashtra, West Bengal, Odisha, and Gujarat -- have high vulnerability to be impacted by the COVID-19 pandemic.

G7 leaders discuss Wuhan lab leak theory behind Covid

G7 leaders discuss Wuhan lab leak theory behind Covid

Rediff.com13 Jun 2021

World leaders gathered at the G7 Summit in Cornwall discussed the possibility that a laboratory leak in central China's Wuhan city may have a connection with the start of the COVID-19 pandemic, with the World Health Organisation (WHO) chief saying all hypotheses behind the origins of the deadly disease remain in play.

Amid Omicron surge, new Covid variant 'IUH' found in France

Amid Omicron surge, new Covid variant 'IUH' found in France

Rediff.com4 Jan 2022

The B.1.640.2 variant has been reported by researchers at institute IHU Mediterranee Infection in at least 12 cases, and has been linked to travel to African country Cameroon.

COVID-19: Kids face greater risk than previously thought, says study

COVID-19: Kids face greater risk than previously thought, says study

Rediff.com12 May 2020

According to the study, published in JAMA Pediatrics, children are more likely to get very sick if they have other chronic conditions like obesity. "It is also important to note that children without chronic illness are also at risk. Parents need to continue to take the virus seriously," said coauthor of the study.

NASA images reveal how we light up the world at night

NASA images reveal how we light up the world at night

Rediff.com13 Apr 2017

NASA has released new global maps of Earth at night.

Does India need booster shots to fight Omicron?

Does India need booster shots to fight Omicron?

Rediff.com12 Dec 2021

'Better to prevent than to wait for evidence. Protection delayed can also mean protection denied'

1 in 4 experience mild side effects from Covishield: Lancet study

1 in 4 experience mild side effects from Covishield: Lancet study

Rediff.com28 Apr 2021

The researchers from King's College London in the United Kingdom also found that most systemic side effects -- meaning side effects excluding where the injection took place -- peaked within the first 24 hours following vaccination and usually lasted 1-2 days.

India's 3rd Covid wave likely to peak on Jan 23: IIT prof

India's 3rd Covid wave likely to peak on Jan 23: IIT prof

Rediff.com19 Jan 2022

Delhi, Mumbai and Kolkata have already reached their peak in case numbers in the past seven days, said Manindra Agrawal, a professor at IIT Kanpur and one of the researchers associated with the Sutra Covid model.

Israeli embassy blast: Probe agencies yet to identify any suspect

Israeli embassy blast: Probe agencies yet to identify any suspect

Rediff.com1 Feb 2021

However, the probe agencies stressed that all angles were being covered in the probe.